Also, antifungal therapy can be given for afebrile patients with neutropenia who are at higher risk of fungal infection (eg, after hematopoietic stem cell transplantation or intensive chemotherapy for acute myeloid leukemia or who have a myelodysplastic disorder or a history of prior fungal infections).